Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cell-permeable, mitochondrial-targeted, peptide antioxidants.

Hazel H Szeto1

  • 1Department of Pharmacology, Joan and Sanford I. Weill Medical College of Cornell University, 1300 York Avenue, New York, NY 10021, USA. hhszeto@med.cornell.edu

The AAPS Journal
|June 27, 2006
PubMed
Summary

Szeto-Schiller peptides offer targeted antioxidant delivery to mitochondria, effectively combating cellular oxidative injury and preventing cell death. These novel peptides show promise for treating various diseases, including neurodegenerative disorders and ischemia-reperfusion injury.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mitochondrial cargo quality determines the paracrine effects of extracellular vesicles derived from vascular endothelial cells.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2025
Same author

Telomere length in offspring is determined by mitochondrial-nuclear communication at fertilization.

Nature communications·2025
Same author

Genome-Wide CRISPR Screen Identifies Phospholipid Scramblase 3 as the Biological Target of Mitoprotective Drug SS-31.

Journal of the American Society of Nephrology : JASN·2024
Same author

SS-31 as a Mitochondrial Protectant in the Treatment of Tendinopathy: Evaluation in a Murine Supraspinatus Tendinopathy Model.

The Journal of bone and joint surgery. American volume·2022
Same author

Structure-activity relationships of mitochondria-targeted tetrapeptide pharmacological compounds.

eLife·2022
Same author

Evaluation of SS-31 as a Potential Strategy for Tendinopathy Treatment: An In Vitro Model.

The American journal of sports medicine·2022

Area of Science:

  • Mitochondrial biochemistry
  • Antioxidant pharmacology
  • Cellular redox biology

Background:

  • Cellular oxidative injury is linked to aging and diseases like neurodegeneration and ischemia-reperfusion.
  • Existing antioxidants are often ineffective due to poor targeting, especially when mitochondria are the primary source of reactive oxygen species (ROS).

Purpose of the Study:

  • To introduce and evaluate Szeto-Schiller (SS) peptides as novel antioxidants with targeted delivery to the inner mitochondrial membrane.
  • To investigate the mechanism of action and therapeutic potential of SS peptides in preventing oxidative cell death.

Main Methods:

  • Design of SS peptides with an aromatic-cationic structure for mitochondrial targeting.
  • Assessment of SS peptide antioxidant activity, including scavenging of hydrogen peroxide and peroxynitrite, and inhibition of lipid peroxidation.

Related Experiment Videos

  • Evaluation of SS peptide efficacy in preventing mitochondrial permeability transition and cytochrome c release.

    • Main Results:

    • SS peptides concentrate over 1000-fold in the inner mitochondrial membrane.
    • SS peptides effectively scavenge ROS and inhibit oxidant-induced cell death with nanomolar potency.
    • Preclinical studies demonstrate potential applications in ischemia-reperfusion injury and neurodegenerative diseases.

    Conclusions:

    • SS peptides represent a novel class of antioxidants with targeted mitochondrial delivery.
    • These peptides exhibit potent antioxidant activity and favorable "druggable" properties.
    • SS peptides hold promise for treating a range of diseases associated with oxidative stress and mitochondrial dysfunction.